Not applicableUnknownNCT05371392What this trial is testingPolymorphism of ITGA4 Gene in Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Sohag University 80
Very early researchLooking for participantsNCT07428707What this trial is testingImmune Profiling of CLL/SLL Treated With First-Line PirtobrutinibWho this might be right forChronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL) National Heart, Lung, and Blood Institute (NHLBI) 30
Testing effectiveness (Phase 2)Study completedNCT00004907What this trial is testingChemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's LymphomaWho this might be right forLymphoma Northwestern University
Not applicableStudy completedNCT00716911What this trial is testingMeasuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell TransplantWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more City of Hope Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT01125176What this trial is testingAlternating Thalidomide and Lenalidomide Therapy Plus Rituximab (ThRiL) as Initial Treatment for Patients With CLLWho this might be right forChronic Lymphocytic Leukemia Weill Medical College of Cornell University 15
Not applicableEnded earlyNCT01077440What this trial is testingPresence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantWho this might be right forCancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more Vanderbilt University 24
Large-scale testing (Phase 3)Ended earlyNCT00416910What this trial is testingCombination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia German CLL Study Group 83
Testing effectiveness (Phase 2)WithdrawnNCT02371590What this trial is testingLenalidomide and Obinutuzumab for Previously Untreated CLLWho this might be right forChronic Lymphocytic Leukemia University of California, San Diego
Testing effectiveness (Phase 2)Active Not RecruitingNCT02756897What this trial is testingVenetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic LeukemiaRecurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+3 more M.D. Anderson Cancer Center 234
Testing effectiveness (Phase 2)Ended earlyNCT05272813What this trial is testingInvestigate the Efficacy and Safety of MS-553 in CLL/SLLWho this might be right forLymphocytic LeukemiaSmall Lymphocytic Lymphoma Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07674810What this trial is testingTrial Of The Combination Of Zanubrutinib, Sonrotoclax, And Obinutuzumab For Patients With Treatment-Naïve Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia M.D. Anderson Cancer Center 40
Early research (Phase 1)Study completedNCT01373229What this trial is testingLenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)Who this might be right forLeukemia, Lymphocytic, Chronic, B-Cell David Rizzieri, MD 21
Not applicableStudy completedNCT01675102What this trial is testingAllogeneic Hematopoietic Stem Cell Transplantation (HSCT) in 17p- Chronic Lymphocytic Leukemia (CLL)Who this might be right forCLL European Society for Blood and Marrow Transplantation 41
Large-scale testing (Phase 3)Active Not RecruitingNCT01886872What this trial is testingRituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic LeukemiaWho this might be right forStage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic LeukemiaStage III Chronic Lymphocytic Leukemia+1 more National Cancer Institute (NCI) 547
Not applicableStudy completedNCT04872621What this trial is testingCalquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient InvestigationWho this might be right forRelapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma) AstraZeneca 104
Testing effectiveness (Phase 2)Study completedNCT01314014What this trial is testingImexon for Relapsed Follicular and Aggressive LymphomasWho this might be right forFollicular LymphomaSmall Lymphocytic LymphomaMarginal Zone Lymphoma+4 more University of Rochester 22
Not applicableStudy completedNCT00281814What this trial is testingCaregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow TransplantWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more The Cleveland Clinic 36
Early research (Phase 1)WithdrawnNCT03807063What this trial is testingRivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell TransplantWho this might be right forAcute Bilineal LeukemiaMyelodysplastic/Myeloproliferative NeoplasmMyelodysplastic/Myeloproliferative Neoplasm, Unclassifiable+9 more Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT07516093What this trial is testingStudy of NX-5948 Versus Pirtobrutinib in R/R CLL/SLLWho this might be right forB-cell LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Nurix Therapeutics, Inc. 620
Testing effectiveness (Phase 2)Ended earlyNCT05405309What this trial is testingRP-3500 and Olaparib in DNA Damage Repair Pathway Deficient Relapsed/Refractory Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia University of Utah 5